Tuberculosis and Respiratory Diseases

The Korean Academy of Tuberculosis and Respiratory Diseases (대한결핵및호흡기학회)
권호 표지
DOI QR코드

DOI QR Code

Diffuse Alveolar Hemorrhage

  • Park, Moo Suk (Division of Pulmonology, Department of Internal Medicine, Severance Hospital, Institute of Chest Diseases, Yonsei University College of Medicine)
  • Received : 2012.12.17
  • Accepted : 2012.12.28
  • Published : 2013.04.30
Download PDF
⟨ Previous Next ⟩

Abstract

Diffuse alveolar hemorrhage (DAH) is a life-threatening and medical emergency that can be caused by numerous disorders and presents with hemoptysis, anemia, and diffuse alveolar infiltrates. Early bronchoscopy with bronchoalveolar lavage is usually required to confirm the diagnosis and rule out infection. Most cases of DAH are caused by capillaritis associated with systemic autoimmune diseases such as anti-neutrophil cytoplasmic antibody-associated vasculitis, anti-glomerular basement membrane disease, and systemic lupus erythematosus, but DAH may also result from coagulation disorders, drugs, inhaled toxins, or transplantation. The diagnosis of DAH relies on clinical suspicion combined with laboratory, radiologic, and pathologic findings. Early recognition is crucial, because prompt diagnosis and treatment is necessary for survival. Corticosteroids and immunosuppressive agents remain the gold standard. In patients with DAH, biopsy of involved sites can help to identify the cause and to direct therapy. This article aims to provide a general review of the causes and clinical presentation of DAH and to recommend a diagnostic approach and a management plan for the most common causes.

Keywords

References

  1. Collard HR, Schwarz MI. Diffuse alveolar hemorrhage. Clin Chest Med 2004;25:583-92. https://doi.org/10.1016/j.ccm.2004.04.007
  2. Colby TV, Fukuoka J, Ewaskow SP, Helmers R, Leslie KO. Pathologic approach to pulmonary hemorrhage. Ann Diagn Pathol 2001;5:309-19. https://doi.org/10.1053/adpa.2001.27923
  3. Lara AR, Schwarz MI. Diffuse alveolar hemorrhage. Chest 2010;137:1164-71. https://doi.org/10.1378/chest.08-2084
  4. Ioachimescu OC, Stoller JK. Diffuse alveolar hemorrhage: diagnosing it and finding the cause. Cleve Clin J Med 2008;75:258-80. https://doi.org/10.3949/ccjm.75.4.258
  5. Cordier JF, Cottin V. Alveolar hemorrhage in vasculitis: primary and secondary. Semin Respir Crit Care Med 2011;32:310-21. https://doi.org/10.1055/s-0031-1279827
  6. Brown KK. Pulmonary vasculitis. Proc Am Thorac Soc 2006;3:48-57. https://doi.org/10.1513/pats.200511-120JH
  7. Newsome BR, Morales JE. Diffuse alveolar hemorrhage. South Med J 2011;104:269-74. https://doi.org/10.1097/SMJ.0b013e3182126d3b
  8. Ewan PW, Jones HA, Rhodes CG, Hughes JM. Detection of intrapulmonary hemorrhage with carbon monoxide uptake: application in goodpasture's syndrome. N Engl J Med 1976;295:1391-6. https://doi.org/10.1056/NEJM197612162952502
  9. Specks U. Diffuse alveolar hemorrhage syndromes. Curr Opin Rheumatol 2001;13:12-7. https://doi.org/10.1097/00002281-200101000-00003
  10. Schnabel A, Holl-Ulrich K, Dalhoff K, Reuter M, Gross WL. Efficacy of transbronchial biopsy in pulmonary vaculitides. Eur Respir J 1997;10:2738-43. https://doi.org/10.1183/09031936.97.10122738
  11. Travis WD, Colby TV, Lombard C, Carpenter HA. A clinicopathologic study of 34 cases of diffuse pulmonary hemorrhage with lung biopsy confirmation. Am J Surg Pathol 1990;14:1112-25. https://doi.org/10.1097/00000478-199012000-00003
  12. Fauci AS, Haynes BF, Katz P, Wolff SM. Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 1983;98:76-85. https://doi.org/10.7326/0003-4819-98-1-76
  13. Jayne D. Evidence-based treatment of systemic vasculitis. Rheumatology (Oxford) 2000;39:585-95. https://doi.org/10.1093/rheumatology/39.6.585
  14. Frankel SK, Schwarz MI. The pulmonary vasculitides. Am J Respir Crit Care Med 2012;186:216-24. https://doi.org/10.1164/rccm.201203-0539CI
  15. Klemmer PJ, Chalermskulrat W, Reif MS, Hogan SL, Henke DC, Falk RJ. Plasmapheresis therapy for diffuse alveolar hemorrhage in patients with small-vessel vasculitis. Am J Kidney Dis 2003;42:1149-53. https://doi.org/10.1053/j.ajkd.2003.08.015
  16. Henke D, Falk RJ, Gabriel DA. Successful treatment of diffuse alveolar hemorrhage with activated factor VII. Ann Intern Med 2004;140:493-4. https://doi.org/10.7326/0003-4819-140-6-200403160-00033
  17. Ahmed SH, Aziz T, Cochran J, Highland K. Use of extracorporeal membrane oxygenation in a patient with diffuse alveolar hemorrhage. Chest 2004;126:305-9. https://doi.org/10.1378/chest.126.1.305
  18. Keogh KA, Wylam ME, Stone JH, Specks U. Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody- associated vasculitis. Arthritis Rheum 2005;52: 262-8. https://doi.org/10.1002/art.20718
  19. Jayne D, Rasmussen N, Andrassy K, Bacon P, Tervaert JW, Dadoniene J, et al. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med 2003;349:36-44. https://doi.org/10.1056/NEJMoa020286
  20. Stone JH, Tun W, Hellman DB. Treatment of non-life threatening Wegener's granulomatosis with methotrexate and daily prednisone as the initial therapy of choice. J Rheumatol 1999;26:1134-9.
  21. Wegener's Granulomatosis Etanercept Trial (WGET) Research Group. Etanercept plus standard therapy for Wegener's granulomatosis. N Engl J Med 2005;352:351-61. https://doi.org/10.1056/NEJMoa041884
  22. Specks U. Chapter 22. Pulmonary vasculitis. In: Schwarz MI, King TE Jr, editors. Interstitial lung disease. 4th ed. Hamilton: BC Decker Inc.; 2003. p. 599-631.
  23. Lynch JP, Leatherman. Chapter 77. Alveolar hemorrhage syndrome. In: Fisherman AP, Elias JA, Fishman JA, Grippi MA, Senior RM, Pack AI, editors. Fishman's pulmonary diseases and disorders. 4th ed. New York: McGraw Hill Inc.; 2008. p. 1281-97.
  24. Ahn JH. Pulmonary vasculitis. Tuberc Respir Dis 2000 48:825-36. https://doi.org/10.4046/trd.2000.48.6.825
  25. Chang TW. Chapter 10-3. Pulmonary vasculitis and diffuse alveolar hemorrhage syndrome. In: The Korean Academy of Tuberculosis and Respiratory Diseases, editor. Respiratory diseases. Seoul: Koonja Publishing Inc.; 2004. p. 549-61.
  26. Betensley AD, Yankaskas JR. Factor viia for alveolar hemorrhage in microscopic polyangiitis. Am J Respir Crit Care Med 2002;166:1291-2. https://doi.org/10.1164/ajrccm.166.9.267d
  27. Channick RN, Rubin LJ. Chapter 49. Pulmonary vasculitis and primary pulmonary hypertension. In: Mason RJ, Broaddus VC, Murray JF, Nadel JA, editors. Murray and Nadel's textbook of respiratory medicine. 4th ed. Philadelphia: Elsevier Saunders Inc.; 2005. p. 1459-65.
  28. Travis WD, Koss MN. Pulmonary vasculitis. In: Dail DH, Hammar SP, editors. Pulmonary pathology. 2nd ed. Berlin: Springer-Verlag, Inc.; 1994. p. 1027-95.
  29. Kang KH. Diffuse alveolar hemorrhage syndrome. In: Tuberc Respir Dis Workshop, 1999 Nov 13, Seoul, Korea. Seoul: The Korean Academy of Tuberculosis and Respiratory Disease; 1999. p. 43-52.

Cited by

  1. Pristane-Induced Granulocyte Recruitment Promotes Phenotypic Conversion of Macrophages and Protects against Diffuse Pulmonary Hemorrhage in Mac-1 Deficiency vol.193, pp.10, 2013, https://doi.org/10.4049/jimmunol.1401051
  2. Late-onset Systemic Lupus Erythematosus with Protein-losing Enteropathy, Vitiligo, and Diffuse Alveolar Hemorrhage vol.38, pp.3, 2013, https://doi.org/10.12771/emj.2015.38.3.121
  3. EMBOLIZATION OF BRONCHIAL ARTERIES IN ACUTE PULMONARY BLEEDING IN CHILDREN vol.174, pp.2, 2015, https://doi.org/10.24884/0042-4625-2015-174-2-63-69
  4. Differential diagnosis of diffuse alveolar haemorrhage in immunocompromised patients vol.28, pp.4, 2013, https://doi.org/10.1097/qco.0000000000000181
  5. Diffuse Alveolar Hemorrhage in Systemic Lupus Erythematosus: Histopathologic Features and Clinical Correlations vol.2017, pp.None, 2013, https://doi.org/10.1155/2017/1936282
  6. A Case of Leptospirosis-Associated Severe Pulmonary Hemorrhagic Syndrome Successfully Treated with Venovenous Extracorporeal Membrane Oxygenation vol.2017, pp.None, 2013, https://doi.org/10.1155/2017/5369267
  7. Lung involvement in childhood onset granulomatosis with polyangiitis vol.15, pp.1, 2013, https://doi.org/10.1186/s12969-017-0150-8
  8. Pulmonary vasculitis and pulmonary hemorrhage vol.2017, pp.1, 2013, https://doi.org/10.5339/qmj.2017.swacelso.44
  9. Recurrent alveolar hemorrhage: How do you treat that which you cannot see? vol.25, pp.None, 2013, https://doi.org/10.1016/j.rmcr.2018.09.002
  10. Diffuse Alveolar Hemorrhage Induced by Vaping vol.2018, pp.None, 2013, https://doi.org/10.1155/2018/9724530
  11. The Bleeding Pneumonia - A Review of Diffuse Alveolar Hemorrhage vol.3, pp.1, 2013, https://doi.org/10.17925/usrpd.2018.13.1.33
  12. A case of life-threatening intraoperative diffuse alveolar hemorrhage during a femur fracture operation with suspected fat embolism - A case report - vol.13, pp.1, 2013, https://doi.org/10.17085/apm.2018.13.1.77
  13. Negative Pressure Pulmonary Hemorrhage after Laryngospasm during the Postoperative Period vol.33, pp.3, 2013, https://doi.org/10.4266/acc.2016.00689
  14. Emergent Complications of Rheumatoid Arthritis vol.55, pp.5, 2013, https://doi.org/10.1016/j.jemermed.2018.07.030
  15. Dark bronchus sign: a subtle indication of diffuse alveolar haemorrhage vol.12, pp.7, 2013, https://doi.org/10.1136/bcr-2019-230991
  16. Severe Pneumonitis with Alveolar Hemorrhage Associated with Herbal Medicines: A Case Report vol.86, pp.5, 2013, https://doi.org/10.1272/jnms.jnms.2019_86-504
  17. Warfarin-induced diffuse alveolar hemorrhage: Case report and a review of the literature vol.36, pp.6, 2019, https://doi.org/10.4103/lungindia.lungindia_8_19
  18. Alveolar Hemorrhage, a Rare and Life-Threatening Complication of Catastrophic Antiphospholipid Syndrome vol.2019, pp.None, 2013, https://doi.org/10.1155/2019/3284258
  19. Emerging Risk Profile of Lung Cancer Therapy: Diffuse Alveolar Hemorrhage from Osimertinib vol.2019, pp.None, 2013, https://doi.org/10.1155/2019/6185943
  20. A Case of Acute Life-Threatening Pulmonary Hemorrhage from Synthetic Cannabinoid Abuse vol.2019, pp.None, 2013, https://doi.org/10.1155/2019/8137648
  21. Neutrophil extracellular traps are associated with the pathogenesis of diffuse alveolar hemorrhage in murine lupus vol.100, pp.None, 2013, https://doi.org/10.1016/j.jaut.2019.03.009
  22. Immunoadsorption and autologous transplantation for life-threatening primary antiphospholipid syndrome vol.3, pp.17, 2019, https://doi.org/10.1182/bloodadvances.2019000465
  23. Bleeding pneumonia: Diffuse alveolar hemorrhage due to human metapneumovirus vol.21, pp.None, 2013, https://doi.org/10.1016/j.idcr.2020.e00894
  24. Leptospirosis manifested with severe pulmonary haemorrhagic syndrome successfully treated with venovenous extracorporeal membrane oxygenation vol.13, pp.1, 2013, https://doi.org/10.1136/bcr-2019-230075
  25. Coronavirus SARS-CoV-2: Hypotheses of Impact on the Circulatory System, Prospects for the Use of Perfluorocarbon Emulsion, and Feasibility of Biophysical Research Methods vol.16, pp.3, 2013, https://doi.org/10.15360/1813-9779-2020-3-0-1
  26. Diffuse Alveolar Hemorrhage Following Pirfenidone Initiation vol.33, pp.4, 2020, https://doi.org/10.1177/0897190019841731
  27. Treatment of Diffuse Alveolar Hemorrhage: Controlling Inflammation and Obtaining Rapid and Effective Hemostasis vol.22, pp.2, 2013, https://doi.org/10.3390/ijms22020793
  28. Post partum dyspnoea: look beyond the lungs vol.17, pp.1, 2013, https://doi.org/10.1183/20734735.0114-2020
  29. The Significance of Subpleural Sparing in CT Chest: A State-of-the-Art Review vol.361, pp.4, 2013, https://doi.org/10.1016/j.amjms.2021.01.008
  30. Does withdrawal of immunosuppression in rheumatoid arthritis after SARS-CoV-2 infection increase the risk of vasculitis? vol.14, pp.4, 2013, https://doi.org/10.1136/bcr-2020-241125
  31. Utilization of extracorporeal life support for diffuse alveolar damage and diffuse alveolar hemorrhage: A systematic review vol.45, pp.6, 2013, https://doi.org/10.1111/aor.13861
  32. Diffuse alveolar haemorrhage secondary to haemophilus influenzae in a vaping patient vol.14, pp.6, 2013, https://doi.org/10.1136/bcr-2021-242701
  33. Exosomes Derived from Human Umbilical Cord Mesenchymal Stem Cells Regulate Macrophage Polarization to Attenuate Systemic Lupus Erythematosus-Associated Diffuse Alveolar Hemorrhage in Mice vol.14, pp.3, 2013, https://doi.org/10.15283/ijsc20156
  34. Negative-pressure-related diffuse alveolar hemorrhage after monitored anesthesia care for vertebroplasty: a case report vol.15, pp.1, 2021, https://doi.org/10.1186/s13256-021-02697-6